Reforming Payment for Clinician-Administered Drugs - Most-Favored-Nation Pricing in Medicare Part B.
Saved in:
| Title: | Reforming Payment for Clinician-Administered Drugs - Most-Favored-Nation Pricing in Medicare Part B. |
|---|---|
| Authors: | Hwang TJ; Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston., Clemans-Cope L; Health Policy Division, Urban Institute, Washington, DC., Kesselheim AS; Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston. |
| Source: | The New England journal of medicine [N Engl J Med] 2026 May 07; Vol. 394 (18), pp. 1774-1777. Date of Electronic Publication: 2026 May 02. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
